<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药笔记 | wechat-feeds</title><link>https://wechat.privacyhide.com/</link><description>乘之愈往，识之愈真。如将不尽，与古为新。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 24 Jan 2021 23:33:47 +0800</pubDate><image><url>http://wx.qlogo.cn/mmhead/Q3auHgzwzM69fibT90EQVnrmdB4DT7QfMyPj1m6rZSIcykf3Ecs4Vcw/64</url><title>医药笔记 | wechat-feeds</title><link>https://wechat.privacyhide.com/</link><width>64</width><height>64</height></image><item><title>未来已来：肿瘤新抗原疫苗</title><link>https://mp.weixin.qq.com/s/3QtoJps7fQomT6xADrrIjQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBshoz3iczMxqj5tGYTeg0g5ibauqAHJ0y9Kwo2Imia5fKEnmcpht3wSW8AWX9Ohia76HAe9gXdwhMDkw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>华人科学家做了许多开创性工作]]></content:encoded><pubDate>Sun, 24 Jan 2021 21:12:37 +0800</pubDate></item><item><title>FDA一个月连批两款狼疮肾炎药物：Voclosporin获批</title><link>https://mp.weixin.qq.com/s/i595Nj0A8GwqbES-jCRv5w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAbq0fLVVpyiblZQBRhsZgxUzcEzYF7w5908d3vrvdAJEEvlxy5hgsx5Iac84IxBv3bqyPzDIWBKWg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>新型环孢素]]></content:encoded><pubDate>Sat, 23 Jan 2021 15:04:29 +0800</pubDate></item><item><title>IgA：对抗新冠病毒感染中发挥重要作用</title><link>https://mp.weixin.qq.com/s/EjOyligA_8M2-FLyeDegjQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAbq0fLVVpyiblZQBRhsZgxUib5rbic3QGjEvvwYxXWq4eYvJOhq1QpN5B7YrxVDUAb87dA3Cjd8bFfQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>IgA]]></content:encoded><pubDate>Sat, 23 Jan 2021 15:04:29 +0800</pubDate></item><item><title>辉瑞GUCY2c/CD3双抗</title><link>https://mp.weixin.qq.com/s/xb0xtMpp1zjKmUssGeZWIA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAbq0fLVVpyiblZQBRhsZgxUVNSrOuZwVSzL5oiaAcY3cNwuP7rkTXtaiaL9RAlmxb01ks9De37M7nXw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>GUCY2c/CD3]]></content:encoded><pubDate>Sat, 23 Jan 2021 15:04:29 +0800</pubDate></item><item><title>石药集团抗体药全梳理</title><link>https://mp.weixin.qq.com/s/esNDXS9v0I2i_caW-8D0AQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNCDf0LJVFuzyk5mJNHh4QgL70UwFPia0QgRWANia76pibRDbNvTH6ic7Cfoz4cI5b6odfSePZOiaU8cW4w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>单抗、双抗、ADC、FIC]]></content:encoded><pubDate>Fri, 22 Jan 2021 19:52:58 +0800</pubDate></item><item><title>Incyte向FDA递交PD-1抗体上市申请，再鼎医药拥有中国权益</title><link>https://mp.weixin.qq.com/s/kD7szZ36wREGtU8BY4DEew</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAeeQRVmbTz1raiaZicy4zzGjREco5hx0J1s8UxtkT2DiaHKtSic3QMT0cp1AaCTx24IsbbxibHDoeumoA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>再鼎医药7750万美元引进大中华区权益]]></content:encoded><pubDate>Fri, 22 Jan 2021 19:52:58 +0800</pubDate></item><item><title>默克PD-L1/TGFβ双抗临床失败，国内多家药企在研</title><link>https://mp.weixin.qq.com/s/defcN2cQrJteNlk8M9U06Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNCDf0LJVFuzyk5mJNHh4QgLQk8tiasjUCQYOHUJ0obO2HfZhESvX2ThSgwyLSvUbDyokKRiaEsIODibA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Fast Follow前置必然面对的风险]]></content:encoded><pubDate>Wed, 20 Jan 2021 23:34:27 +0800</pubDate></item><item><title>Merus与礼来达成16.8亿美元合作，贝达药业、先声药业均引进其双抗</title><link>https://mp.weixin.qq.com/s/ktxMT2516mHJasdLdsIbkQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDnzJfiaoo95L3zyjIAnpPZSwNb1e0xDOb9GPuhnYMzp9scm9Pzjlga1HksKASsTXWicch6vKqWiaEWQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>License-in技术也越来越普遍]]></content:encoded><pubDate>Wed, 20 Jan 2021 06:50:01 +0800</pubDate></item><item><title>CD47-SIRPα轴肿瘤免疫疗法：靶向SIRPα</title><link>https://mp.weixin.qq.com/s/aPa4bguxBDETWRbtFmMAaQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDnzJfiaoo95L3zyjIAnpPZSmCMicOYO4EaUn1caLAOFRn1wBIeDbwYwXMkbXh8h5ribhUhYRianfpKIg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>SIRPα]]></content:encoded><pubDate>Wed, 20 Jan 2021 06:50:01 +0800</pubDate></item><item><title>国内首家：东阳光申报GLP-1/FGF21双功能分子</title><link>https://mp.weixin.qq.com/s/lH7r0aY4Iy91olis96_WVw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDnzJfiaoo95L3zyjIAnpPZS2Ee0poibXx6RKG7OgRGyab3NMVNOosFJwficDSV5C5nZw9g5fXH8QXibw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>NASH]]></content:encoded><pubDate>Wed, 20 Jan 2021 06:50:01 +0800</pubDate></item><item><title>东阳光申报德谷胰岛素：国内第6家</title><link>https://mp.weixin.qq.com/s/UaOa_1bS6G1Ju901eU8ZoA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDnzJfiaoo95L3zyjIAnpPZSsth4rIm1eZ23kKpm7qstXDbpxNTG7zic9MNWMNu0eGyZvshNOTafzSQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>海正、四环、联邦、正大天晴、博唯、东阳光]]></content:encoded><pubDate>Wed, 20 Jan 2021 06:50:01 +0800</pubDate></item><item><title>2020年国内大分子新药研发格局</title><link>https://mp.weixin.qq.com/s/mPJzGHhGLoplDLRF5NI48g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBXbx9vh7okOb2hz9asVW71a8npnfUk7iaiate1oFsEyqeuwbvd0GSOQbdRwzzL4CZY8JoibafPBA6Qw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>278]]></content:encoded><pubDate>Tue, 19 Jan 2021 08:58:29 +0800</pubDate></item><item><title>纽福斯申报眼病基因疗法NR082</title><link>https://mp.weixin.qq.com/s/eapIVVhHVH6skpRdehOIPw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDnzJfiaoo95L3zyjIAnpPZS6QcAQ9TuXRTfFM2vzlGlXkmZYDYh4cZPFavq4K3RhrHf1eZXaoYDicw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>LHON]]></content:encoded><pubDate>Tue, 19 Jan 2021 08:58:29 +0800</pubDate></item><item><title>北京科兴新冠疫苗获巴西批准</title><link>https://mp.weixin.qq.com/s/B4vegY1Bn8F3TOTDRa1CaQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBXbx9vh7okOb2hz9asVW71OmSW6yXG65274sbAUaiayujK0ggicDIXbyib9qbS8NqqYfENy0Qib90njQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CoronaVac]]></content:encoded><pubDate>Mon, 18 Jan 2021 11:21:48 +0800</pubDate></item><item><title>Blood：默沙东ROR1 ADC药物治疗里氏转化淋巴瘤</title><link>https://mp.weixin.qq.com/s/aUhuGeiUKtdRvl6WwwbjRg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBvoOTXPnZBwwOHUL6WBY4w5yt8wDAwnXagLIY55BTyuLgaQJql67OJMsIIErgica7KuvBMvvOYHiag/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>VLS-101]]></content:encoded><pubDate>Sun, 17 Jan 2021 20:42:08 +0800</pubDate></item><item><title>ABL Bio：B7-H3/4-1BB双抗</title><link>https://mp.weixin.qq.com/s/ZnEF98O2B03m2R8b34Nrpg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBvoOTXPnZBwwOHUL6WBY4waqlYxd1dyqz2GZa1AUL4ib9nZ7wYu603NuS9G3868pKRib8T7Sibkvib2w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>ABL Bio、天境生物]]></content:encoded><pubDate>Sun, 17 Jan 2021 20:42:08 +0800</pubDate></item><item><title>DS-8201获FDA批准治疗胃癌</title><link>https://mp.weixin.qq.com/s/xlXlyRivd5jMt3ZgT3IHVA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAKDYp2lEAuPKT22Ic13pcE6FBwXceBic0VK6hvzWchAicAeiaYo44uKypJDxxiagaIBZjqnJUQx40ibEQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>新一代HER2 ADC]]></content:encoded><pubDate>Sat, 16 Jan 2021 09:13:10 +0800</pubDate></item><item><title>CD38抗体Darzalex获批第二个适应症：轻链淀粉样变性</title><link>https://mp.weixin.qq.com/s/UKjPs1XNQdaLuq1do4ZG4w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAKDYp2lEAuPKT22Ic13pcESC9E7JByIYLpolVpIJDrFw6WLUKY1PtyRDCz0WLHhqicuhDSFdJvanw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>B细胞异常]]></content:encoded><pubDate>Sat, 16 Jan 2021 09:13:10 +0800</pubDate></item><item><title>友芝友新型双抗平台：四价对称</title><link>https://mp.weixin.qq.com/s/v8FumQ9XiweEEY1pgmmh8w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDP243GfY0lOGQXSm2flzA48xa2Z9upBta6FxXvAIFMia23HuIBH6XMLrL02npRJdhnbRfQvum8ibfg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>从YBODY到四价对称]]></content:encoded><pubDate>Fri, 15 Jan 2021 07:29:11 +0800</pubDate></item><item><title>细胞因子新疗法：BioNtech启动IL-2+IL-7临床试验</title><link>https://mp.weixin.qq.com/s/mzX383uxcWGsEEegNizzwQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDP243GfY0lOGQXSm2flzA4PqbibR7PPWJeXkopr7Z2QdWl8teyEa7x3Cic6icibsO7lYPKPliaLKmtv7Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>IL-2、IL-7同时与PD-L1抗体联用，显著提高疗效。]]></content:encoded><pubDate>Fri, 15 Jan 2021 07:29:11 +0800</pubDate></item></channel></rss>